IOLCPNSEIOL CHEM AND PHARMA LTD· PharmaceuticalsMinimalNeutral
Announced Sat, 17 Oct, 2026 · 13:04 IST

Newspaper notice on special window for physical share dematerialisation

IOLCP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.8%Reaction day
₹194.40
prior close
₹194.68
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.7%-4.1% vs market
Pharmaceuticals peers, median of 172sector-1.6%-4.2% vs sector

On the reaction day the stock moved 4.1 pts less than Nifty Microcap 250 and 4.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-2.0
10m
-2.6
15m
-2.9
30m
-3.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.8-1.7-4.1-1.6-4.2
Next day
-10.2-4.2-5.9-3.5-6.7
2d
-12.1-5.2-6.9-3.7-8.5
3d
-14.6-7.4-7.2-5.3-9.3
4d
-13.6-7.0-6.5-4.1-9.5
5d
-7.2-5.5-1.7-2.3-4.8
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

IOL Chemicals and Pharmaceuticals has submitted copies of a newspaper publication, as required by SEBI, informing shareholders about a one-time special window from 5 February 2026 to 4 February 2027. This window lets shareholders re-lodge transfer and dematerialisation requests for physical shares where the original transfer deed was executed before 1 April 2019 but was earlier returned, rejected, or unattended. Re-lodged shares will be processed only in demat form and will carry a one-year lock-in after transfer registration.

Likely market impact

Routine SEBI compliance filing under Regulation 30. No material impact on shareholders or stock price.